Cancer research
Research from Japan has shed light on a new mechanism by which certain small molecules, represented by MeBS, sensitize cancer cells to apoptosis (programmed cell death). The study, led by S. Kim and colleagues from the National Institute of Health Science, found that MeBS modulates the ubiquitylation and distribution of
Cancer research
Recent studies in the United States have explored the potential of oncolytic adenoviruses as a treatment for brain tumors. These viruses are engineered to selectively target cancer cells, and researchers are investigating ways to improve their potency and selectivity. According to a study published in Current Opinion In Molecular Therapeutics,
Cancer research
A new study led by researchers at Ohio State University has identified a cancer-specific protein, Piwil2-like (PL2L) protein, that is present in a wide range of cancer types and at all stages of tumor development. This protein, also known as PL2L60, has been detected in various human cancer cell lines,
Cancer
In a groundbreaking study, researchers from the University of New Mexico have discovered that amifostine, a radioprotective agent, significantly enhances the anti-cancer effects of paclitaxel in endometrial cancer cells. The study, published in the International Journal of Oncology, reveals that the synergistic effect between amifostine and paclitaxel is dependent on
Cancer
Results from a Phase IIb/III trial of the new drug afatinib in patients with lung adenocarcinoma showed that those who had already been treated with the EGFR inhibitors erlotinib or gefitinib seemed to gain further benefits in terms of progression-free survival and tumor shrinkage. Dr Vincent Miller from Memorial
Cancer research
Researchers at the University of Texas M.D. Anderson Cancer Center have made a groundbreaking discovery in the understanding of pain mechanisms. According to a study published in Neuropharmacology, dehydroepiandrosterone sulfate (DHEAS) significantly potentiates N-methyl-d-aspartate (NMDA)-induced spontaneous pain behaviors in mice. The study reveals that DHEAS facilitates nociception by
Cancer research
Recent research from Osaka, Japan, has identified two genetic markers that can predict resistance to chemotherapy in gastric carcinoma patients. The study, published in the Annals of Surgical Oncology, found that tumors with allelic imbalance at the p53 locus and/or microsatellite instability (MSI) were significantly more resistant to neoadjuvant
Cancer
Researchers from New York University's College of Dentistry have been awarded a $1.25 million grant to study the molecular mechanisms of oral cancer pain, with the ultimate goal of developing more effective pain medications. Led by Dr. Brian L. Schmidt, a Professor of Oral and Maxillofacial Surgery,
Cancer
Scientists have developed a novel vaccine approach for cancer immunotherapy by engineering tumor cells to codisplay on their surface costimulatory proteins, such as 4-1BBL and LIGHT. This approach, known as ProtEx technology, involves generating immunological ligands with core streptavidin (SA) and displaying them on biotinylated cells in a rapid and
Cancer
Recent research has presented a fresh understanding of melanomas, a type of skin cancer, using genetic engineering of T cells to target the ganglioside GD2, a tumor-associated antigen found in a high proportion of melanoma cells. The study, published in Clinical Cancer Research, reveals that genetically engineered T cells can
Cancer
American Apparel, a clothing manufacturer and distributor, was sued by the US Equal Employment Opportunity Commission (EEOC) for terminating a disabled garment worker while he was on medical leave for cancer treatment. The EEOC argues that the company denied the worker's request for reasonable accommodation and fired him
Cancer research
Scientists have discovered a high incidence of methicillin-resistant Staphylococcus aureus (MRSA) infections in breast implant recipients, prompting concerns about antibiotic treatment. According to a recent report, bacterial infection is a well-known risk of breast implant surgery, occurring in 2.0 to 2.5 percent of cosmetic cases and up to
